Dec 13, 2023
NOT FOR PUBLICATION, DISTRIBUTION, OR DISCLOSURE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION...
Nov 9, 2023
This is a translation of the Swedish press release published 2023-11-09, 07:55 CET New successful results from the completed independent clinical trial in Ireland show that Neola® measures oxygen in the lungs of 100% of the participating 100 newborn babies....
Aug 17, 2023
Press communication Lund, Sweden, August 17, 2023 This is a translation of the Swedish press release published 2023-08-17 Neola Medical AB (the “Company”) has appointed ABG Sundal Collier (“ABGSC”) as liquidity provider for the Company’s shares listed on Nasdaq...
Aug 15, 2023
This is a translation of the Swedish press release published 2023-08-15, 08.00 CEST Neola Medical AB (publ) today publishes the Q2 report of 2023 (in Swedish). The report is available at the company’s website and is attached to the press release. During the...
May 17, 2023
This is a translation of the Swedish press release published 2023-05-17, 08.00 CET Neola Medical AB (publ) today publishes the Q1 report of 2023 (in Swedish). The report is available at the company’s website and is attached to the press release. Attendance at...
Apr 12, 2023
This is a translation of the Swedish press release 2023-04-12 Shareholders in Neola Medical AB, org.nr 559069–9012 (”the Company”), are hereby given notice of the annual general meeting the 17th of May 2023 at 13.00 in the Company’s office at Ideon Gateway floor...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
